SCM
AZN icon

Seascape Capital Management’s AstraZeneca AZN Stock Holding History

Seascape Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61M Buy
24,305
+222
+0.9% +$41.8K 1.1% 37
2026
Q1 		$4.75M Sell
24,083
-84
-0.3% -$16.2K 1.37% 28
2025
Q4 		$4.44M Buy
24,167
+292
+1% +$51.2K 1.26% 30
2025
Q3 		$3.66M Buy
23,875
+2,565
+12% +$388K 1.05% 39
2025
Q2 		$2.98M Sell
21,310
-134
-0.6% -$18.8K 0.94% 41
2025
Q1 		$3.15M Buy
21,444
+289
+1% +$41.8K 1.1% 33
2024
Q4 		$2.77M Buy
21,155
+516
+3% +$72.2K 0.97% 40
2024
Q3 		$3.22M Sell
20,639
-753
-4% -$122K 1.15% 33
2024
Q2 		$3.34M Buy
21,392
+64
+0.3% +$9.63K 1.24% 29
2024
Q1 		$2.89M Buy
21,328
+343
+2% +$45.4K 1.07% 36
2023
Q4 		$2.83M Buy
20,985
+902
+4% +$117K 1.19% 32
2023
Q3 		$2.72M Sell
20,083
-47
-0.2% -$6.42K 1.29% 29
2023
Q2 		$2.88M Sell
20,130
-678
-3% -$99.8K 1.37% 24
2023
Q1 		$2.89M Sell
20,808
-2,284
-10% -$307K 1.47% 25
2022
Q4 		$3.13M Buy
23,092
+365
+2% +$45.8K 1.71% 17
2022
Q3 		$2.49M Sell
22,727
-145
-0.6% -$18.4K 1.71% 21
2022
Q2 		$3.02M Buy
22,872
+92
+0.4% +$12.1K 1.83% 15
2022
Q1 		$3.02M Buy
22,780
+704
+3% +$84.4K 1.57% 26
2021
Q4 		$2.57M Buy
22,076
+457
+2% +$53.8K 1.21% 37
2021
Q3 		$2.6M Buy
21,619
+3,627
+20% +$422K 1.33% 35
2021
Q2 		$2.15M Buy
17,992
+1,246
+7% +$137K 1.12% 39
2021
Q1 		$1.67M Buy
16,746
+2,185
+15% +$220K 0.93% 43
2020
Q4 		$1.46M Sell
14,561
-735
-5% -$77.8K 0.85% 44
2020
Q3 		$1.68M Buy
15,296
+434
+3% +$48.3K 1.06% 39
2020
Q2 		$1.57M Buy
+14,862
New +$1.53M 1.13% 32
2020
Q1 		– Sell
-15,950
Closed -$1.59M – 69
2019
Q4 		$1.59M Buy
+15,950
New +$1.5M 1.14% 41

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Seascape Capital Management's AZN Position: Q2 2026 in Review

Seascape Capital Management increased its AstraZeneca (AZN) stake by 0.92% in Q2 2026, buying an estimated $41.8K and bringing the position to 24,305 shares worth $4.61M. The position accounts for 1.1% of the portfolio, ranked #37.

Seascape Capital Management first reported a position in AZN in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.75M in Q1 2026. 633 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Seascape Capital Management held 24,305 shares of AstraZeneca worth $4.61M as of Q2 2026.
  • Seascape Capital Management bought 222 AstraZeneca shares in Q2 2026, an estimated $41.8K.
  • AstraZeneca made up 1.1% of Seascape Capital Management's portfolio in Q2 2026, its #37 holding.
  • Seascape Capital Management first reported a position in AstraZeneca in Q4 2019 and has held it in 26 quarters since.
  • Seascape Capital Management's AstraZeneca position peaked at $4.75M in Q1 2026.
  • 633 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Seascape Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.